UNITED THERAPEUTICS Corp 4

Richard Giltner received 1,310 United Therapeutics Corp common shares upon vesting of restricted stock units, bringing his direct holdings to 21,884 shares.

On July 9, 2026, Richard Giltner, an insider at United Therapeutics Corp, acquired 1,310 shares of common stock upon the vesting and settlement of an equal number of restricted stock units, which converted on a one-for-one basis into common shares at no exercise price. Following this routine equity compensation event, Giltner’s direct ownership increased to 21,884 shares of United Therapeutics common stock. Because no sale occurred and no price was paid, the transaction represents standard compensation-related RSU vesting rather than an open-market purchase or discretionary sale.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001460472-26-000001

Alert Tier

4